Welcome to Paid Research Studies




  • Conditions:   Aging;   Aphasia
    Interventions:   Behavioral: Moderate Intensity Exercise;   Behavioral: Gentle Stretching
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Adductor Spasmodic Dysphonia
    Intervention:   Behavioral: Voice Exercise
    Sponsor:   University of Wisconsin, Madison
    Recruiting

  • Conditions:   MLD;   Krabbe Disease;   ALD;   MPS I;   MPS II;   MPS III;   Vanishing White Matter Disease;   GM3 Gangliosidosis;   PKAN;   Tay-Sachs Disease;   NP Deficiency;   Osteopetrosis;   Alpha-Mannosidosis;   Sandhoff Disease;   Niemann-Pick Diseases;   MPS IV;   Gaucher Disease;   GAN;   GM1 Gangliosidoses;   Morquio Disease;   S-Adenosylhomocysteine Hydrolase Deficiency;   Batten Disease;   Pelizaeus-Merzbacher Disease;   Leukodystrophy;   Lysosomal Storage Diseases;   Purine Nucleoside Phosphorylase Deficiency;   Multiple Sulfatase Deficiency Disease
    Interventions:   Other: Palliative Care;   Biological: Hematopoetic Stem Cell Transplantation
    Sponsor:   University of Pittsburgh
    Recruiting

  • Condition:   Aphasia
    Interventions:   Behavioral: Treatment ABAB;   Behavioral: Treatment BABA
    Sponsors:   University of Nebraska Lincoln;   Quality Living
    Not yet recruiting

  • Conditions:   Apraxia of Speech;   Non-fluent Aphasia;   Primary Progressive Aphasia;   Primary Progressive Nonfluent Aphasia
    Intervention:   Diagnostic Test: Testing protocol for the study
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Aphasia;   Traumatic Brain Injury
    Intervention:   Behavioral: Comprehension Acquired Brain Injury
    Sponsors:   Miami University;   Duquesne University;   University of Nebraska Lincoln;   University of Arizona
    Recruiting

  • Conditions:   Critical Illness;   Communication Disabilities
    Interventions:   Behavioral: EMPOWER;   Other: Usual Care
    Sponsors:   Weill Medical College of Cornell University;   New York Hospital Queens;   Memorial Sloan Kettering Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Aphasia, Acquired
    Intervention:   Device: Transcranial Magnetic Stimulation
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Condition:   Autism Spectrum Disorder
    Interventions:   Behavioral: Social Communication Growth Charts (SCGC);   Behavioral: Parent-Implemented (P-I) Condition;   Behavioral: Clinician-Implemented (C-I) Condition
    Sponsor:   Emory University
    Not yet recruiting

  • Condition:   Primary Progressive Aphasia With Suspected Alzheimer's Disease
    Interventions:   Drug: 18F-AV-1451;   Device: PET
    Sponsors:   Northwestern University;   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   Concussion;   Mild Traumatic Brain Injury;   Cognitive Communication Disorder
    Intervention:   Other: Early cognitive-communication therapy
    Sponsors:   Northern Arizona University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Reading Problem
    Interventions:   Behavioral: Reading;   Behavioral: Mindset;   Behavioral: Reading Embedded with Mindset;   Behavioral: Business as Usual
    Sponsors:   Vanderbilt University;   Southern Methodist University;   Florida State University
    Recruiting

  • Condition:   Frontotemporal Dementia
    Intervention:   Drug: Syntocinon
    Sponsors:   Lawson Health Research Institute;   Weston Foundation;   Canadian Institutes of Health Research (CIHR);   Berry Consultants
    Not yet recruiting

  • Conditions:   Frontotemporal Lobar Degeneration;   Amytrophic Lateral Sclerosis;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Alzheimer Disease, Early Onset;   Alzheimer Disease;   Alzheimer Disease, Late Onset;   Dementia, Alzheimer Type;   Logopenic Progressive Aphasia;   Primary Progressive Aphasia;   Visuospatial/Perceptual Abilities;   Posterior Cortical Atrophy;   Executive Dysfunction;   Corticobasal Degeneration;   Ideomotor Apraxia
    Intervention:  
    Sponsors:   University of California, Los Angeles;   National Institute on Aging (NIA);   University of Southern California
    Recruiting

  • Conditions:   Frontotemporal Dementia;   Behavioral Variant Frontotemporal Dementia
    Intervention:   Other: Assessments
    Sponsor:   Biogen
    Recruiting

  • Condition:   Frontotemporal Dementia
    Interventions:   Drug: 18F-AV-1451;   Drug: 18F-AV-45
    Sponsor:   Avid Radiopharmaceuticals
    Recruiting

  • Condition:   Apraxia Speech
    Intervention:   Device: Transcranial Magnetic Stimulation (TMS)
    Sponsor:   University of Miami
    Recruiting

  • Condition:   Aphasia
    Interventions:   Behavioral: Language therapy;   Behavioral: Background Music;   Behavioral: Aerobic Exercise
    Sponsor:   New York University School of Medicine
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Learning Disability
    Interventions:   Drug: Lovastatin 20 MG;   Behavioral: reading tutoring intervention;   Drug: Placebo Oral Tablet;   Behavioral: sham tutoring;   Drug: Lovastatin 40 MG
    Sponsors:   Vanderbilt University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Niemann-Pick Disease, Type C1
    Intervention:   Drug: Hydroxypropyl-beta-cyclodextrin
    Sponsor:   CTD Holdings, Inc.
    Recruiting

  • Condition:   Aphasia
    Intervention:   Behavioral: Semantic Feature Analysis (SFA)
    Sponsors:   Boston University Charles River Campus;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Stroke
    Interventions:   Device: Anodal or Cathodal tDCS;   Device: Sham;   Behavioral: Computerized naming therapy
    Sponsors:   Johns Hopkins University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: Transcranial Magnetic Stimulation
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Frontotemporal Dementia (FTD)
    Interventions:   Drug: Lithium Carbonate;   Drug: Placebo
    Sponsors:   Columbia University;   Alzheimer’s Drug Discovery Foundation
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Interventions:   Drug: Folinic Acid;   Other: Placebo
    Sponsors:   Emory University;   Arkansas Children's Hospital Research Institute;   Harvard University
    Not yet recruiting

  • Conditions:   Atypical Alzheimer's Disease;   Logopenic Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
    Interventions:   Drug: F-18 AV 1451;   Drug: C-11 PiB
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting

  • Condition:   Attention-Deficit/Hyperactivity Disorder
    Interventions:   Behavioral: Care Manager;   Other: ADHD Portal
    Sponsors:   Children's Hospital of Philadelphia;   Patient-Centered Outcomes Research Institute
    Recruiting

  • Conditions:   Aphasia, Primary Progressive;   Anomia;   Alzheimer Disease
    Interventions:   Behavioral: Phonological;   Behavioral: Orthographic;   Behavioral: Semantic;   Behavioral: Lexical;   Behavioral: Untrained
    Sponsors:   Georgetown University;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Johns Hopkins University
    Recruiting

  • Condition:   Aphasia
    Interventions:   Device: Active tDCS plus Speech-Language Therapy;   Device: Sham plus Speech-Language Therapy
    Sponsor:   Johns Hopkins University
    Recruiting

  • Conditions:   Primary Progressive Aphasia;   MCI;   FTD
    Interventions:   Device: Active tDCS plus Speech-Language Therapy;   Device: Sham plus Speech-Language Therapy
    Sponsor:   Johns Hopkins University
    Recruiting

  • Conditions:   Apraxias;   Communication Disorders;   Speech Disorders
    Interventions:   Device: EPG Tx;   Behavioral: SPT
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: J-EMT for Toddlers with Autism
    Sponsors:   Vanderbilt University;   Northwestern University
    Recruiting

  • Conditions:   Autism Spectrum Disorder;   Moderate Language Delay
    Interventions:   Behavioral: Direct Instruction-Language for Learning (DI-LL);   Behavioral: Treatment as Usual
    Sponsor:   Emory University
    Recruiting

  • Condition:   Familial Frontotemporal Dementia
    Intervention:  
    Sponsors:   Mayo Clinic;   National Institute on Aging (NIA);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting

  • Conditions:   Aphasia;   CVA;   Apraxia of Speech
    Intervention:   Behavioral: Sound Production Treatment (SPT)
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Stroke and Aphasia
    Intervention:   Behavioral: Communal singing
    Sponsor:   Beth Israel Medical Center
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
    Intervention:  
    Sponsors:   University of Miami;   National Institute of Neurological Disorders and Stroke (NINDS);   National Center for Advancing Translational Science (NCATS);   St. Jude Children's Research Hospital;   ALS Association
    Recruiting

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: transcranial direct current stimulation
    Sponsor:   Northwell Health
    Recruiting

  • Conditions:   Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn;   Alpha-Mannosidosis;   Sanfilippo Mucopolysaccharidoses
    Intervention:   Biological: DUOC-01
    Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation
    Recruiting

  • Condition:   Aphasia
    Interventions:   Device: transcranial direct current stimulation;   Other: Non-Prime Condition;   Behavioral: Traditional behavioral treatment
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Conditions:   Language Impairment;   Down Syndrome
    Intervention:   Behavioral: Jasper-EMT with words and AAC
    Sponsors:   Vanderbilt University;   University of California, Los Angeles
    Recruiting

  • Conditions:   Lysosomal Storage Disorders;   Gaucher Disease;   Fabry Disease;   Pompe Disease;   Niemann-Pick Disease
    Intervention:  
    Sponsor:   O & O Alpan LLC
    Recruiting

  • Conditions:   Aphasia;   Stroke
    Intervention:   Behavioral: Speech Production Treatment
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
    Intervention:  
    Sponsor:   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   Aphasia;   Stroke
    Intervention:   Behavioral: Naming therapy
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Intellectual Disabilities;   Speech Delay;   Language Disorder
    Intervention:   Behavioral: Pivotal Response Treatment (PRT)
    Sponsor:   Stanford University
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Lobar Degeneration
    Intervention:  
    Sponsors:   National Institute of Neurological Disorders and Stroke (NINDS);   National Institute on Aging (NIA)
    Recruiting

  • Conditions:   PPA;   Non-fluent Aphasia;   Apraxia of Speech;   Primary Progressive Non-fluent Aphasia;   Primary Progressive Aphasia
    Intervention:   Drug: FDG Fluorodeoxyglucose 18
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Condition:   Aphasia
    Interventions:   Device: Activa Dose II Real tDCS;   Device: Activa Dose II Sham tDCS
    Sponsors:   University of South Carolina;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Medical University of South Carolina
    Recruiting

  • Condition:   Autism Spectrum Disorders
    Intervention:   Procedure: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   Johns Hopkins University
    Recruiting

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: ISC+PRT Intervention
    Sponsors:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   U.S. Department of Education
    Recruiting

  • Conditions:   Aphasia;   Stroke
    Intervention:   Device: Magstim SuperRapid
    Sponsors:   University of Alabama at Birmingham;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic;   Muscular Dystrophy;   Miyoshi Myopathy
    Intervention:  
    Sponsors:   University of Massachusetts, Worcester;   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Aphasia;   Stroke;   Cerebrovascular Accident;   Apoplexy;   Cerebral Infarction
    Interventions:   Behavioral: Melodic Intonation Therapy;   Behavioral: Speech-Repetition-Therapy
    Sponsors:   Beth Israel Deaconess Medical Center;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Conditions:   Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
    Intervention:   Other: Genetic study of ALS families
    Sponsor:   Northwestern University
    Recruiting

  • Condition:   Primary Progressive Aphasia
    Intervention:  
    Sponsors:   Northwestern University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

  • Condition:   Neimann-Pick Disease, Type C
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Condition:   Stuttering
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting